ReviewVascular health and risk management2017

Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance.

Nazanin Aghel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.